
Quotient Limited QTNT
Quarterly report 2022-Q4
added 02-09-2023
Quotient Limited DSO Ratio 2011-2026 | QTNT
Annual DSO Ratio Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 45.1 | 60.4 | 41.9 | 42.2 | 42 | 44.7 | 35.8 | 45.1 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60.4 | 35.8 | 44.7 |
Quarterly DSO Ratio Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.2 | 16.9 | 29.2 | - | 50 | 15 | 21.9 | 45.1 | 47.3 | 47.2 | 29.8 | 56.3 | 53.8 | 52 | 46.9 | 31.9 | 33 | 36.6 | 41.9 | - | 34.9 | 40.6 | 35.8 | - | 52.7 | 17.2 | 17.8 | - | 37.7 | 14.7 | 20.1 | - | 52.4 | 18.5 | 24.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 56.3 | 14.7 | 35.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.48 | -5.49 % | $ 468 M | ||
|
Biodesix
BDSX
|
41.7 | $ 13.64 | -6.58 % | $ 1.77 B | ||
|
DarioHealth Corp.
DRIO
|
56.7 | $ 8.45 | - | $ 33.7 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 477.84 | -2.25 % | $ 180 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
IDEXX Laboratories
IDXX
|
43.5 | $ 565.93 | -1.28 % | $ 45.5 B | ||
|
Illumina
ILMN
|
61.3 | $ 118.67 | -4.61 % | $ 18.9 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.61 | -0.62 % | $ 61.9 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 238.69 | -2.47 % | $ 25.5 B | ||
|
Co-Diagnostics
CODX
|
101 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.21 | -0.86 % | $ 385 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 158.35 | -4.21 % | $ 7.85 B | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
Waters Corporation
WAT
|
306 | $ 291.81 | -2.91 % | $ 17.4 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.75 | 3.38 % | $ 2.55 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.55 | -10.52 % | $ 388 M | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
Exagen
XGN
|
51.2 | $ 2.68 | -4.12 % | $ 57.8 M | ||
|
Interpace Biosciences
IDXG
|
53.1 | $ 1.73 | 2.37 % | $ 7.59 M | ||
|
RadNet
RDNT
|
34.5 | $ 56.85 | -4.31 % | $ 4.27 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 6.54 | -0.3 % | $ 273 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 266.88 | -0.56 % | $ 22.2 B | ||
|
VolitionRx Limited
VNRX
|
52.3 | $ 0.2 | 0.03 % | $ 19.2 M | ||
|
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
28.1 | $ 26.75 | -1.65 % | $ 34.7 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.11 | -2.06 % | $ 912 M | ||
|
Neuronetics
STIM
|
48.7 | $ 1.4 | 5.26 % | $ 92.3 M |